Changes in the Managing Board of HELIX IMMUNO-ONCOLOGY S.A.

On 4th June 2022, the Extraordinary General Meeting of shareholders of Helix Immuno-Oncology S.A. adopted resolutions concerning changes in the Managing Board by entrusting the function of the President of the Managing Board to Mr Ireneusz Fąfara and the function of the Vice-President of the Managing Board to Mr Paweł Wiśniewski, effective from 5th June 2020.

Since 5th June 2020, the Managing Board of the Company comprises two persons, namely:

1. Ireneusz Fąfara – President of the Managing Board
2. Paweł Wiśniewski – Vice-President of the Managing Board.